Biohaven Pharmaceuticals

human brain abstract art
Biotech

Biohaven flunks depression trial, adding to CNS release concerns

As the biopharma wound down for the holidays, the company reported the failure of a midphase study of BHV-7000 for the treatment of MDD.
Nick Paul Taylor Jan 2, 2026 4:48am
Graphic image of a red thumbs down against a blue background

FDA rejects Biohaven approval request, triggering cost cutting

Nov 5, 2025 4:02am
Garbage truck picking up trash on suburban street

Biohaven trashes troriluzole in OCD after ph. 3 fail

Aug 12, 2025 2:06pm
delay FDA delay

FDA delays decision on Biohaven troriluzole filing, plans adcomm

May 15, 2025 6:02am
brain money funding

Biohaven lands funding Oberland funding deal worth up to $600M

Apr 28, 2025 4:43pm
long shot miss basketball hoop fail shoot

Biohaven's biopolar med fails pivotal test

Mar 3, 2025 5:14pm